Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133600) titled 'Augmentation of Different Intervention Strategy for Bipolar II Disorder Patients with Rhythm Disturbance' on Sept. 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
First-episode or recurrent drug-naive bipolar II disorder
Intervention:
Group M:Quetiapine
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-09-30
Target Sample Size: Group M:108;Group I:108;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=289429
Publish...